United States · FDA National Drug Code directory
PROPOFOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-4699_85df7d34-d827-46d8-aba9-c99c116f654a
- Product NDC
- 0409-4699
- Form
- INJECTION, EMULSION
- Composition / generic term
- PROPOFOL
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20060403
- Source listing expiry
- 20271231
Source-listed ingredients
- PROPOFOL — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 TRAY (0409-4699-24) / 100 mL in 1 VIAL (0409-4699-54) · 0409-4699-24
- 20 VIAL in 1 TRAY (0409-4699-33) / 50 mL in 1 VIAL (0409-4699-53) · 0409-4699-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →